Live Breaking News & Updates on Brand Switch Fee

Stay updated with breaking news from Brand switch fee. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Decision to secure supply of clomipramine hydrochloride and mirtazapine tablets


Decision to secure supply of clomipramine hydrochloride and mirtazapine tablets
22 July 2021
What we’re doing
mirtazapine and
clomipramine hydrochloride tablets following the announcement that Apotex New Zealand Limited (Apotex), the current supplier, is leaving the New Zealand market.
This decision means that:
Mirtazapine 30 mg and 45 mg tablets
A new brand of 30 mg and 45 mg mirtazapine tablets will be funded from 1 August 2021.  This will be the Noumed brand, supplied by Noumed Pharmaceuticals Limited (Noumed).
The Apo-Mirtazapine brand of mirtazapine (supplied by Apotex) will continue to be funded until 1 January 2022. 
From 1 January 2022, the Noumed brand of 30 mg and 45 mg mirtazapine tablets will be the only funded brand of 30 mg and 45 mg mirtazapine tablets until 30 June 2024. ....

New Zealand , New Zealanders , Clomipramine Teva , Code Of Health , Health Navigator , Disability Services Consumer Rights Code Of , Teva Pharma New Zealand Limited , Apotex New Zealand Limited , Ministry Of Health , Noumed Pharmaceuticals Limited , Teva Pharma , Brand Switch Fee , Pharmaceutical Schedule , Nurse Practitioners , Registered Nurse Prescribers , Medicines Act , Nurse Prescribers , Disability Services Consumer , Brand Swich Fee , புதியது ஜீலாந்து , குறியீடு ஆஃப் ஆரோக்கியம் , ஆரோக்கியம் நேவிகேட்டர் , அமைச்சகம் ஆஃப் ஆரோக்கியம் , தேவா பார்மா , மருந்து அட்டவணை , செவிலியர் ப்ர்யாக்டிஶநர்ஸ் ,